New Delhi, August 30: A single deep breath will soon be enough to vaccinate children against measles as human trials of an inhalable vaccine for the deadly disease are expected to begin early next year in India.
Serum Institute of India will be conducting the trials of the new vaccine in the country.
“The phase-I trials are expected to begin by the first quarter of next year once the animal testing, currently under process, is completed,” Prasad Kulkarni, Additional Medical Director, Serum Institute of India told PTI.
The vaccine is expected to hit the market in 2.5-3 years after the trials begin, Kulkarni added.
The US scientists, who have developed the dry powder vaccine against measles, say the inhalable vaccine will reduce the risks of needle infections like HIV and hepatitis and greatly benefit developing countries.
–PTI